Instil Bio, Inc.
+13.5% · 90d
$8.13
+0.07 (+0.93%)
After-Hours $8.13(+0.00)
News
(1)March 2026
Instil Bio, Inc. — 8-K Filing
TILInstil Bio, Inc.
# 🧾 What This Document Is This is an **8-K filing**, which is like a company's "major news bulletin" for the stock market. Instil Bio is using it to report its financial results for the last quarter and full year of 2025, but more importantly, to announce a major strategic shift. They've stopped de
Read summaryView on SEC EDGAR
Peers in Biotechnology
VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%